Atypical presentation of an atypical bacteria - Mycoplasmapneumoniae

Tanu Sagar1, Anusha Rathi1, Vinayaraj Ev1

  • 1Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.

Insights

Mycoplasma pneumoniae can cause facial palsy in children, even without typical pneumonia symptoms. Early diagnosis via PCR is crucial for recognizing this neurological complication.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Neurology

Background:

  • Mycoplasma pneumoniae (Mp) is a common cause of atypical pneumonia in children and adults.
  • While typically causing mild to moderate respiratory illness, Mp can lead to severe pulmonary and extrapulmonary complications.
  • Neurological manifestations of Mp infection are recognized but less common.

Observation:

  • A six-year-old child presented with facial palsy.
  • The child had no significant respiratory signs or symptoms suggestive of pneumonia.
  • Mycoplasma pneumoniae infection was suspected as the underlying cause.

Findings:

  • Real-time polymerase chain reaction (PCR) assay confirmed Mycoplasma pneumoniae in the cerebrospinal fluid and throat samples.
  • The findings establish a direct link between Mp infection and the child's facial palsy.
  • This case highlights a rare extrapulmonary manifestation of Mycoplasma pneumoniae.

Implications:

  • Clinicians should consider Mycoplasma pneumoniae infection in the differential diagnosis of facial palsy in children, especially when respiratory symptoms are absent.
  • Awareness of potential central nervous system complications associated with Mp is important for timely diagnosis and management.
  • Further research may elucidate the mechanisms linking Mycoplasma pneumoniae to neurological disorders.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
195
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
201
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
135
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
282
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
581